Veritas Bioventions is a leader in developing innovative medical devices for vascular and dental disorders. It was founded in 2009 and has headquarters in India with global operations. The company develops drug-eluting stents, dental implants, and related products and technologies to improve patient outcomes. Key areas of focus include research and development of new coatings, drug delivery systems, small-diameter implants, and digital dentistry solutions. The company's goal is to stimulate continued innovation in medical technology through advancement of minimally invasive procedures.

1. COMPANY OVERVIEW
1 | P a g e
Veritas Bioventions is a leader in the design and development of innovative
medical devices. Our devices help patients with vascular & dental disorders to
return to active and productive lives. We provide physicians with leading-edge
technologies for improved patient management and clinical outcomes. We offer
products, therapies and services that will enhance or extend lives of people
worldwide. Veritas Bioventions was incorporated in 2009; corporate headquarter
is in India, with major operations worldwide. A sales force recognized
throughout the industry for its clinical expertise and customer service insight to
distribute our products.
Continued honest and ethical business conduct has earned Veritas Bioventions
the trust of customers, patients, suppliers, investors, regulators, and fellow
employees, while sustaining our long-term commitment to physicians.
As such, we are committed to being an innovative, unique, world-class
corporation. The only way we achieve this commitment is by providing a high
standard of leadership, along with unquestionable corporate integrity. Our
structure provides the resources of a large organization. The business groups stay
close to the customer and respond quickly to evolving needs. They advance the
organization’s mission of providing leading-edge technology for physicians and
life-saving therapy for patients. At Veritas Bioventions, we believe that advanced
technologies can provide solutions for unmet clinical needs. That's why we work
hard to stimulate a continual stream of innovation in the medical technology
industry.
Vision & Mission
Veritas Bioventions mission is to improve the quality of patient care and the
productivity of health care delivery through the development and advocacy of
less-invasive medical devices and procedures. This is accomplished through the
continuing refinement of existing product and procedures and the investigation
and development of new technologies which can reduce risk, trauma, cost,
procedure time and the need for aftercare.

2. COMPANY OVERVIEW
2 | P a g e
Research and Development
Veritas Bioventions is an advanced stage, research and development company
pursuing the commercialization of the next generation of fully biocompatible
coating for Stents (biocompatible, non-toxic, non-thrombogenic, non-
inflammatory & highly angiogenic) and cutting edge technology for DES. Veritas
Bioventions has engineered a process to produce a carrier that can carry many
classes of therapeutic agents. The projects on DES will address all the
shortcomings of the present commercially available DES. We have also
pioneered in the field of polymer free coating technology in DES with more than
five different proprietary coating technology which are in progress & which will
also address all the future complication of present DES of late thrombosis.
Veritas Bioventions is also working on active drug delivery systems that can
deliver varying combinations and doses of many therapeutic agents including
large and small molecules, proteins, peptides and Genes.
Veritas Bioventions is a milestone ahead in developing a versatile implant
system fulfilling demands of contemporary implantology. We will continue to
lead the dental industry in implant, restorative, regenerative, and digital dentistry
solutions. We remain focused on research and development initiatives that will
improve patient’s quality of life, dentistry will continue to migrate towards more
and more digital solutions for the end benefit of the patient. We will continue to
develop new products that meet the needs of our customers and their patients.
Veritas Bioventions is developing a new implant bio- material made of
zirconium and titanium. Its tensile strength is 60% greater than pure Grade 4
titanium and designed for use in small-diameter implants in narrow interdental
spaces. For clinicians, this new patented bio-material will offer greater
confidence while placing small-diameter implants and the flexibility of having
more treatment options.
Surface chemistry has the potential to alter ionic interaction, protein adsorption,
and cellular activity at the implant surface. These modifications may
subsequently influence conformational changes in the structures and interactive
natures of adsorbed proteins and cells. Furthermore, within the complexities of an
in vivo environment containing multiple protein and cellular interactions, these

3. COMPANY OVERVIEW
3 | P a g e
alterations may differentially regulate biologic events. Hence Veritas
Biovention’s chemically modified sLa surface is in a development phase to
address unmet clinical needs in modern dentistry.
Our present available product range includes:
 Enovo
Everolimus Eluting Coronary Stent on Cobalt Chromium L605
Platform mounted on Rapid Exchange delivery system
The Enovo Coronary Stent System includes loading and elusion of
Everolimus Drug in a controlled fashion on L605 Cobalt
Chromium (Co – Cr alloy) Platform, stent located on balloons
catheter between two platinum iridium radio opaque markers
bands. The drug is encapsulated with several biodegradable
polymers and loaded on the stent through a proprietary coating
technology.
The Enovo is indicated for improving coronary luminal diameter in
patients with symptomatic ischemic heart disease in de novo
coronary artery lesion in native coronary arteries with a reference
vessel diameter of 2.25 mm to 4.0 mm and a lesion length  40
mm. The Enovo is intended for use in patients eligible for
Percutaneous Transluminal Coronary Angioplasty (PTCA).

4. COMPANY OVERVIEW
4 | P a g e
 Sinew
Sirolimus Eluting Coronary Stent on Cobalt Chromium L605
Platform mounted on Rapid Exchange delivery system
The Sinew Coronary Stent System includes loading and elusion of
Sirolimus Drug in a controlled fashion on L605 Cobalt Chromium
(Co – Cr alloy) Platform, stent located on balloons catheter
between two platinum iridium radio opaque markers bands. The
drug is encapsulated with several biodegradable polymers and
loaded on the stent through a proprietary coating technology.
The Sinew is indicated for improving coronary luminal diameter in
patients with symptomatic ischemic heart disease in de novo
coronary artery lesion in native coronary arteries with a reference
vessel diameter of 2.25 mm to 4.0 mm and a lesion length  40
mm. The Sinew is intended for use in patients eligible for
Percutaneous Transluminal Coronary Angioplasty (PTCA).
 Inspire
Paclitaxel Eluting Coronary Stent on Cobalt Chromium L605
Platform mounted on Rapid Exchange delivery system
The Inspire Coronary Stent System includes loading and elusion of
Paclitaxel Drug in a controlled fashion on L605 Cobalt Chromium
(Co – Cr alloy) Platform, stent located on balloons catheter
between two platinum iridium radio opaque markers bands. The
drug is encapsulated with several biodegradable polymers and
loaded on the stent through a proprietary coating technology.
The Inspire is indicated for improving coronary luminal diameter
in patients with symptomatic ischemic heart disease in de novo
coronary artery lesion in native coronary arteries with a reference
vessel diameter of 2.25 mm to 4.0 mm and a lesion length  40
mm. The Inspire is intended for use in patients eligible for
Percutaneous Transluminal Coronary Angioplasty (PTCA).

5. COMPANY OVERVIEW
5 | P a g e
 Endorser Coronary Stent System
Stainless Steel SS316L Stent mounted on Rapid Exchange delivery
system
The Endorser Coronary Stent System includes 316L Stainless Steel
Stent located on balloons catheter between two platinum iridium
radio opaque markers bands. The Endorser stent is indicated for
improving coronary luminal diameter in patients with symptomatic
ischemic heart disease in de novo coronary artery lesion in native
coronary arteries with a reference vessel diameter of 2.25 mm to
4.0 mm and a lesion length  40 mm. The Endorser is intended for
use in patients eligible for Percutaneous Transluminal Coronary
Angioplasty (PTCA). This latest generation design of Endorser
has a unique geometry for controlled & distinctive stent expansion
which enables low stent induced mechanical injury to arterial wall
and excellent vessel conformability.
 Endorser CrCo Coronary Stent System
Cobalt Chromium L605 Stent mounted on Rapid Exchange delivery
system
The Endorser CrCo coronary stent System includes L605 Cobalt
Chromium (Co – Cr alloy) stent located on balloons catheter
between two platinum iridium radio opaque markers bands.
The Endorser CrCo is indicated for improving coronary luminal
diameter in patients with symptomatic ischemic heart disease in de
novo coronary artery lesion in native coronary arteries with a
reference vessel diameter of 2.25 mm to 4.0 mm and a lesion
length  40 mm. The Endorser CrCo is intended for use in patients
eligible for Percutaneous Transluminal Coronary Angioplasty
(PTCA).

6. COMPANY OVERVIEW
6 | P a g e
 Escalate
Inflation Device with / without three way stop-cock
Escalate Disposable Inflation Device is a sterile 30 ATM inflation
devices with a spring loaded Trigger Locking mechanism which is
easy to operate even with wet hands.
The Pressure gauge marking is specially designed for easy pressure
monitoring and fatigue free viewing during the procedure.
 Console
Y-Connector + Guide wire Insertion Tool + Torquer
CONSOLE is a 7.2 Fr device, which is used for coronary
intervention. It has a latest Push –Pull head knob, which ensures
minimal blood and precise navigation of devices in the vasculature.
A specially engineered valve with micro vertical slits which
facilitate smooth manipulation of device and nullify blood loss.
INSERTION TOOL: It is precisely designed for use during
Percutaneous Transluminal Coronary Angioplasty (PTCA) and any
other intravascular therapeutic procedures that utilize a guide wire.
Stainless Steel tube inner ID is 0.60 mm and Hub ID is 0.55 mm,
which provides smooth and resistance free movement of the guide
wire through the hub.
GUIDE WIRE TORQUER provides a mean for maneuvering
guide wires once inserted deep into the vasculature. The brass
collate inside the Torquer can comply to manure guide wires from
0.043” to 0.050”.

7. COMPANY OVERVIEW
7 | P a g e
 WaneCore Dental Implant
WaneCore dental implant is a root-form endosseous implant
system designed to mimic the shape of the tooth for directional
load distribution. WaneCore dental implant is indicated for
surgical placement in the upper or lower jaw arches, to provide a
root form means for single or multiple units’ prosthetic appliance
attachments to restore patient’s chewing function. Implant can be
placed with conventional two stage surgical process with an option
for transmucosal healing or they can be placed in single stage
surgical process for immediate loading.
WaneCore Dental implant has micro channels on the collar,
custom made threads are incorporated on the body of the implant,
have modified surface and a conical connection for post restorative
attachments. Three self tapping groves are given on the apical end
of the implant.
HIGHLIGHTS
Implant design (WaneCore): Parallel wall cylindrical with apical
taper having self tapping micro channels at crestal level for
increased primary stability.
Implant design (WaneCoreXP): Dual tapper implant design with
self cutting deep threads, reverse taper at the neck for bone
preservation, high primary stability in poor bone conditions.
Surface texture: SLA surface for greater BIC (Bone Implant
Contact) & enhanced Osseointegration.
Connection: Conical connection with platform switching benefits
for multiple prosthetic options.

8. COMPANY OVERVIEW
8 | P a g e
 WaneCore Prosthetics
WaneCore Dental Implant system consist of variety of prosthetic
component, all components are manufactured from Biocompatible
grade Titanium Alloy (Ti-6Al-4V Eli), gives various options to the
dentist during the restorative work.
The prosthetic components mainly contain Gingiava Formers for
aesthetic soft tissue integration around the crown, Solid and Hollow
Abutments with wide range of collar heights, Angled Abutments,
UCLA Abutments, Castable abutments and Multi unit abutments for
single or multiple unit’ restoration and Ball overdenture attachments
for full mouth restorations. Transfer coping for open and close tray
technique along with Implant analog.
 WaneCore Surgical Kit
WaneCore Dental Implant system consists of complete surgical kit
& Hybrid Surgical Kit.
WaneCore surgical Kit mainly consist all length & diameters of
Surgical drills for cavity preparation, Parallel Pins and Depth gauge
for accurate cavity measurements, various Implant drivers for
Surgical placement of Dental implant in to the cavity and Adjustable
Torque Wrench for implant placement at various forces.
Individual surgical drills are provided for individual length of the
implant which provides precise and accurate cavity preparation for
implant placement.

9. COMPANY OVERVIEW
9 | P a g e
All surgical drills are laser marked for the easy identification and
manufactured from surgical grade stainless steel with higher
hardness and corrosion resistance properties, these drills are further
coated with DLC coating to increase the life and cutting efficiency
of the drills.
All these surgical kit components are provided in sterilizable
surgical tray with well define color coding and laser marking for
easy identification of all the components.